Activin E enhances insulin sensitivity and thermogenesis by activating brown/beige adipocytes.
Actins
/ genetics
Activins
/ metabolism
Adipocytes, Beige
/ metabolism
Adipocytes, Brown
/ metabolism
Adipose Tissue, Brown
/ metabolism
Adipose Tissue, White
/ metabolism
Animals
Body Temperature
/ drug effects
Energy Metabolism
/ drug effects
Glucose Intolerance
/ metabolism
Insulin Resistance
Mice
Mice, Inbred C57BL
Mice, Transgenic
Thermogenesis
/ drug effects
Uncoupling Protein 1
/ metabolism
INHBE
UCP1
browning/beiging
hepatokine
thermogenesis
Journal
The Journal of veterinary medical science
ISSN: 1347-7439
Titre abrégé: J Vet Med Sci
Pays: Japan
ID NLM: 9105360
Informations de publication
Date de publication:
11 May 2019
11 May 2019
Historique:
pubmed:
19
3
2019
medline:
14
8
2019
entrez:
19
3
2019
Statut:
ppublish
Résumé
Activin E, a secreted peptide encoded by the inhibin/activin βE subunit gene, is a member of the transforming growth factor-β superfamily, which is predominantly expressed in the liver. Recent reports have suggested that activin E plays a role in energy homeostasis as a hepatokine. Here, using transgenic mice overexpressing activin E under the control of the β-actin promoter, we demonstrate that activin E controls energy metabolism through brown/beige adipocytes. The glucose tolerance test and insulin tolerance test showed that the insulin sensitivity was improved in the transgenic mice. Furthermore, the mice had a high body temperature compared with wild-type mice. The transgenic brown adipose tissue and mesenteric white adipose tissue showed upregulation of uncoupling protein 1, which enables energy dissipation as heat by uncoupling oxidative phosphorylation from ATP production. Present results indicate that activin E activates energy expenditure through brown/beige adipocyte activation, suggesting that activin E has high potential for obesity therapy.
Identifiants
pubmed: 30880304
doi: 10.1292/jvms.19-0036
pmc: PMC6541856
doi:
Substances chimiques
Actins
0
Uncoupling Protein 1
0
Activins
104625-48-1
Types de publication
Journal Article
Langues
eng
Pagination
646-652Références
Physiol Rev. 2004 Jan;84(1):277-359
pubmed: 14715917
Biochem Biophys Res Commun. 2006 Mar 10;341(2):416-24
pubmed: 16426570
Mutat Res. 2006 Nov-Dec;613(2-3):123-37
pubmed: 16997617
Horm Metab Res. 2008 Aug;40(8):539-43
pubmed: 18500680
Nature. 2008 Aug 21;454(7207):961-7
pubmed: 18719582
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
Biochem Biophys Res Commun. 2009 Jul 31;385(3):319-23
pubmed: 19463785
Life Sci. 2009 Sep 23;85(13-14):534-40
pubmed: 19703474
Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1244-53
pubmed: 20354155
J Clin Invest. 2012 Feb;122(2):545-52
pubmed: 22269323
Cell Metab. 2012 Mar 7;15(3):395-404
pubmed: 22405074
Cell. 2012 May 11;149(4):871-85
pubmed: 22579288
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):10001-5
pubmed: 22665804
Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
PLoS One. 2012;7(11):e49452
pubmed: 23166672
J Clin Invest. 2013 Jan;123(1):215-23
pubmed: 23221344
Nat Rev Endocrinol. 2013 Mar;9(3):144-52
pubmed: 23337953
Nat Med. 2013 Oct;19(10):1252-63
pubmed: 24100998
Annu Rev Physiol. 2014;76:225-49
pubmed: 24188710
Cell Metab. 2014 May 6;19(5):810-20
pubmed: 24709624
Nat Med. 2015 Apr;21(4):389-94
pubmed: 25774848
Cell Biochem Funct. 2016 Jan;34(1):34-41
pubmed: 26781688
Biochem Biophys Res Commun. 2016 Sep 30;478(4):1746-50
pubmed: 27608598
Cell Rep. 2018 Oct 30;25(5):1193-1203
pubmed: 30380411